Granules India Limited has informed the Exchange regarding Cessation of Dr. Kandiraju Venkata Sitaram Rao (DIN: 08874100) as Joint Managing Director and Chief Executive Officer of the company w.e.f. July 31, 2025.

CEO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹503.55

prior close

₹496.10

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%-0.7% vs market

Pharmaceuticals peers, median of 153sector-0.4%-1.0% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Smallcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.7

15m

+0.5

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4-0.7-0.7-0.4-1.0

Next day

-1.8-0.8-1.0-0.7-1.1

-5.5-1.1-4.3-1.4-4.0

-5.4-1.0-4.4-1.3-4.1

-5.7-1.7-4.1-1.7-4.0

-6.8-3.6-3.1-2.2-4.6

-2.9-4.0+1.1-2.3-0.6

15d

-12.8-8.3-4.5-6.4-6.3

-8.4-6.4-2.1-6.1-2.3

+8.2-3.1+11.2-4.4+12.6

+12.5-4.8+17.3-7.7+20.2

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Kandiraju Venkata Sitaram Rao (Dr. K.V.S. Ram Rao) has resigned from his position as Joint Managing Director and CEO of Granules India Limited, effective from the close of business hours on July 31, 2025. The company officially cited personal reasons for his departure, though his resignation letter references a 'mutual agreement' with the Board. He will also cease to be a Key Managerial Personnel (KMP) of the company. No successor has been named in this disclosure.

Likely market impact

The exit of the Joint MD & CEO at a major pharmaceutical company like Granules India could create short-term uncertainty around leadership and strategy continuity. Investors should watch for announcements regarding a successor and any further clarity on the circumstances of the departure.